M
MedEye Associates | South Miami, FL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
KUS121
Axitinib
EYP-1901
Bimatoprost
THR-149
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
Enrolling
Wet Age Related Macular Degeneration
wAMD
Drug: Aflibercept (2.0 mg)
Drug: EYP-1901
Central retinal artery occlusion (CRAO) is an ophthalmologic emergency which leads to severe and permanent vision loss. There is no evidence-based th...
Active, not recruiting
Central Retinal Artery Occlusion
Drug: KUS121 high dose
Drug: Sham procedure
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects with Neovascular Age- Related Macular Degeneration
Enrolling
Neovascular Age-related Macular Degeneration
Drug: OTX-TKI
Drug: Aflibercept
Trial sponsors
E
K
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems